306 related articles for article (PubMed ID: 9377563)
41. Antiproliferative effect of the C-terminal fragments of parathyroid hormone-related protein, PTHrP-(107-111) and (107-139), on osteoblastic osteosarcoma cells.
Valín A; García-Ocaña A; De Miguel F; Sarasa JL; Esbrit P
J Cell Physiol; 1997 Feb; 170(2):209-15. PubMed ID: 9009150
[TBL] [Abstract][Full Text] [Related]
42. The interleukin-6/soluble interleukin-6 receptor system induces parathyroid hormone-related protein in human osteoblastic cells.
Guillén C; de Gortázar AR; Esbrit P
Calcif Tissue Int; 2004 Aug; 75(2):153-9. PubMed ID: 15129368
[TBL] [Abstract][Full Text] [Related]
43. Midregion parathyroid hormone-related protein inhibits growth and invasion in vitro and tumorigenesis in vivo of human breast cancer cells.
Luparello C; Romanotto R; Tipa A; Sirchia R; Olmo N; López de Silanes I; Turnay J; Lizarbe MA; Stewart AF
J Bone Miner Res; 2001 Dec; 16(12):2173-81. PubMed ID: 11760830
[TBL] [Abstract][Full Text] [Related]
44. Protein kinase C-zeta activation markedly enhances beta-cell proliferation: an essential role in growth factor mediated beta-cell mitogenesis.
Vasavada RC; Wang L; Fujinaka Y; Takane KK; Rosa TC; Mellado-Gil JM; Friedman PA; Garcia-Ocaña A
Diabetes; 2007 Nov; 56(11):2732-43. PubMed ID: 17686945
[TBL] [Abstract][Full Text] [Related]
45. In vivo evidence for progressive activation of parathyroid hormone-related peptide gene transcription with tumor growth and stimulation of osteoblastic bone formation at an early stage of humoral hypercalcemia of cancer.
Yamato H; Nagai Y; Inoue D; Ohnishi Y; Ueyama Y; Ohno H; Matsumoto T; Ogata E; Ikeda K
J Bone Miner Res; 1995 Jan; 10(1):36-44. PubMed ID: 7747629
[TBL] [Abstract][Full Text] [Related]
46. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
47. Parathyroid hormone-related protein induces interleukin 8 production by prostate cancer cells via a novel intracrine mechanism not mediated by its classical nuclear localization sequence.
Gujral A; Burton DW; Terkeltaub R; Deftos LJ
Cancer Res; 2001 Mar; 61(5):2282-8. PubMed ID: 11280799
[TBL] [Abstract][Full Text] [Related]
48. Regulation in vivo of the growth of Leydig cell tumors by antisense ribonucleic acid for parathyroid hormone-related peptide.
Rabbani SA; Gladu J; Liu B; Goltzman D
Endocrinology; 1995 Dec; 136(12):5416-22. PubMed ID: 7588290
[TBL] [Abstract][Full Text] [Related]
49. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
50. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
51. Parathyroid hormone-related peptide.
Kaiser SM; Goltzman D
Clin Invest Med; 1993 Oct; 16(5):395-406. PubMed ID: 8261693
[TBL] [Abstract][Full Text] [Related]
52. Role of interleukin-6 in uncoupling of bone in vivo in a human squamous carcinoma coproducing parathyroid hormone-related peptide and interleukin-6.
Nagai Y; Yamato H; Akaogi K; Hirose K; Ueyama Y; Ikeda K; Matsumoto T; Fujita T; Ogata E
J Bone Miner Res; 1998 Apr; 13(4):664-72. PubMed ID: 9556066
[TBL] [Abstract][Full Text] [Related]
53. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
Brown GM; Morris CA; Mitnick MA; Insogna KL
J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
[TBL] [Abstract][Full Text] [Related]
54. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
Guise TA; Yoneda T; Yates AJ; Mundy GR
J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
[TBL] [Abstract][Full Text] [Related]
55. Inhibitors of Ras farnesylation revert the increased resistance to oxidative stress in K-Ras transformed NIH 3T3 cells.
Santillo M; Mondola P; Gioielli A; Serù R; Iossa S; Annella T; Vitale M; Bifulco M
Biochem Biophys Res Commun; 1996 Dec; 229(3):739-45. PubMed ID: 8954966
[TBL] [Abstract][Full Text] [Related]
56. Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletion.
Sun J; Qian Y; Hamilton AD; Sebti SM
Cancer Res; 1995 Oct; 55(19):4243-7. PubMed ID: 7671229
[TBL] [Abstract][Full Text] [Related]
57. Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumors.
Kukreja SC; Shevrin DH; Wimbiscus SA; Ebeling PR; Danks JA; Rodda CP; Wood WI; Martin TJ
J Clin Invest; 1988 Nov; 82(5):1798-802. PubMed ID: 2846659
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice.
Nakano Y; Watanabe K; Morimoto I; Okada Y; Ura K; Sato K; Kasono K; Nakamura T; Eto S
J Bone Miner Res; 1994 Oct; 9(10):1533-9. PubMed ID: 7817798
[TBL] [Abstract][Full Text] [Related]
59. Antisense inhibition of parathyroid hormone-related peptide gene expression reduces malignant pituitary tumor progression and metastases in the rat.
Akino K; Ohtsuru A; Yano H; Ozeki S; Namba H; Nakashima M; Ito M; Matsumoto T; Yamashita S
Cancer Res; 1996 Jan; 56(1):77-86. PubMed ID: 8548779
[TBL] [Abstract][Full Text] [Related]
60. The potential of farnesyltransferase inhibitors as cancer chemotherapeutics.
Gibbs JB; Oliff A
Annu Rev Pharmacol Toxicol; 1997; 37():143-66. PubMed ID: 9131250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
